A potential impact of artificial intelligence on pharmaceutical drug design and clinical trials

Abstract

Pharmaceutical technology has increasingly integrated artificial intelligence (AI) in recent years. This technology offers significant benefits, including saving time and money while enhancing the understanding of the relationships between various formulation and process parameters. To address both specific and complex challenges, AI leverages human expertise and continually learns from the solutions it produces. Remarkable advances in processing power and AI capabilities could revolutionize drug development. However, the pharmaceutical industry currently faces challenges such as reduced efficiency and rising R&D costs, which hinder its ability to maintain medication development programs. Clinical trials, medication repurposing, drug discovery and development, and improved pharmaceutical production are just a few of the aspects of the pharmaceutical sector where artificial intelligence is increasingly being used. Additionally, by finding qualified individuals, forecasting treatment outcomes, and optimizing accuracy and speed, AI enhances the clinical trial process. AI makes precision treatment possible in personalized medicine by evaluating patient data and forecasting each patient's reaction to treatments.

Ähnliche Arbeiten